Chemical context
Nelfinavir (Viracept) is an FDA approved HIV protease inhibitor identified through structure-based design with a low nanomolar inhibitory concentration against the HIV aspartyl protease (Kaldor et al., 1997) . Although nelfinavir is no longer recommended as a first-line treatment against HIV due to its inferior efficacy compared to alternative protease inhibitors (Panel on Antiretroviral Guidelines, 2015) , it has been found to have a number of additional biological activities that may have therapeutic utility, including antiviral (against other human viruses) (Yamamoto et al., 2004; Kalu et al., 2014) , anticancer (Gantt et al., 2013; Koltai, 2015) , and antivirulence activity (Maxson et al., 2015) . However, nelfinavir was originally designed with only the HIV protease active site in mind and the structure is likely not optimal for binding to the alternative targets involved in these other activities. We recently reported on the synthesis of a collection of nelfinavir analogs that may be of interest for efforts to repurpose the drug (Maxson et al., 2015) .
The syntheses of the title compounds were achieved by a previously reported route that utilizes the configuration of the amino acid starting material to control the stereochemical outcome of the sodium borohydride reduction of the chloromethyl ketone (Kaldor et al., 1997) . However, the reduction of compound (I), derived from achiral glycine, results in a racemic mixture (Fig. 1) , while the reduction of compound (II), derived from l-proline, does not benefit from a strong ISSN 2056-9890 directing influence from the existing chiral center (Fig. 2) . The products of the two reductions were carried forward through the remainder of each synthesis to generate the title compounds. The absolute configurations of compounds (I) and (II), as well as the conformations they adopt due to the increased flexibility and rigidity, respectively, relative to nelfinavir was investigated by X-ray diffraction.
Structural commentary
The core molecular structures of (I) and (II) are comprised of N-tert-butyl-2-(2-hydroxyalkyl)decahydroisoquinoline-3-carboxamide groups. The difference between the two species comes from the substitution at the N position of the decahydroisoquinoline group. Compound (I) has a (2-chloro-4-nitrobenzamido)-2-hydroxypropyl group at the N-atom position of the decahydroisoquinoline ring (Fig. 3) . Compound (II) has a (2-chloro-4-nitrobenzoyl)pyrrolidin-2-yl)-2-hydroxyethyl group at the N-atom position (Fig. 4) . The synthesis of (I).
Figure 2
The synthesis of (II).
Figure 3
Plot showing 35% probability ellipsoids for non-H atoms and circles of arbitrary size for H atoms for (I). Only the major component of disordered sites is shown.
There is disorder of the Cl group in (I) over two positions with the site occupancies refining to 0.941 (8) and 0.059 (8) for Cl1 and Cl1B, respectively. The nitro group is disordered over two positions, with the site occupancies refining to 0.60 (2) and 0.40 (2). The NO 2 group in one orientation is essentially coplanar with the phenyl ring [O1B-N1B-C4-C3; = 1 (2) ] and in the other orientation is twisted slightly more out of plane [O1-N1-C4-C3; = À9. 0 (13) ]. Both sixmembered rings of the decahydroisoquinoline group in (I) adopt a chair conformation, the dihedral angle between the best-fit planes of the cyclohexyl and piperidine moieties is 119. 9 (15) . There is one intramolecular hydrogen-bonding interaction in (I) which involves the two carboxamide groups (N2-H2Á Á ÁO5; Table 1 ). The Flack x parameter of À0.008 (18) and the Hooft y parameter of À0.010 (19) indicate that the absolute configuration of (I) has been assigned correctly.
There are multiple disordered moieties in (II), the nitro group is disordered over two positions with the site occupancies for the two orientations refining to 0.967 (6) and 0.033 (8). In both orientations, the NO 2 group is twisted out of the plane of the phenyl ring; the major orientation is twisted out of the plane less [O1-N1-C3-C2; = 10. 9 (4) ] than the minor orientation [O1B-N1B-C3-C2; = À26 (6) ]. The carbonyl C7-O3 group is disordered over two positions, with the site occupancies refining to 0.58 (2) and 0.42 (2). In the minor orientation, the CO group is nearly normal to the plane of the phenyl ring [O3B-C7B-C6-C5; = À89 (3) ], while the major orientation is significantly less out of plane [O3-C7-C6-C5; = À44 (3) ]. The final two disordered moieties of (II) are a portion of the pyrrolidin-2-yl group and the three methyl groups of tert-butyl. The C10 and C11 atoms of the pyrrolidin-2-yl group are disordered over two positions, with site occupancies of 0.669 (16) and 0.331 (16). The tert-butyl methyl groups are also disordered over two positions via a slight rotation around the N4-C24 bond, the site occupancies refining to 0.811 (17) and 0.189 (17). Similar to (I), both sixmembered rings of the decahydroisoquinoline group in (II) adopt a chair conformation, with a dihedral angle between the best-fit planes of the cyclohexyl and piperidine moieties of 116.3 (17) . There is one weak intramolecular hydrogenbonding interaction in (II), involving the N-tert-butyl carboxamide group and the 2-hydroxyl O atom (N4-H4CÁ Á ÁO4; Table 2 ). The Flack x parameter of 0.036 (19) and the Hooft y parameter of 0.03 (2) indicate that the absolute configuration of (II) has been assigned correctly.
Supramolecular features
The extended structure of (I) is a two-dimensional sheet of hydrogen-bonded molecules extending in the ac plane (Fig. 5a ). Each molecule of (I) is hydrogen bonded to four neighboring molecules via O-HÁ Á ÁO and N-HÁ Á ÁO interactions; the details of these interactions can be found in Table 1 . The two-dimensional layers stack in an ABAB pattern along the crystallographic b axis (Fig. 5b) . The layers are separated by the bulky decahydroisoquinoline groups, which protrude above and below the sheets. The layers alternate between these bulky groups pointing 'left' and 'right', this along with a slight offset between the A and B layers allows them to interdigitate.
The extended structure of (II) is a one-dimensional chain of hydrogen-bonded molecules extending parallel to the crystallographic a axis (Fig. 6a) . Each molecule of (II) is hydrogen bonded to two neighboring molecules via O-HÁ Á ÁO interactions, the details of these interactions can be found in Table 2 . The one-dimensional chains are separated by the bulky decahydroisoquinoline groups and the tert-butyl groups, which prevent the chains from linking via further hydrogenbonding interactions (Fig. 6b) . Plot showing 35% probability ellipsoids for non-H atoms and circles of arbitrary size for H atoms for (II). Only the major component of disordered sites is shown.
Table 1
Hydrogen-bond geometry (Å , ) for (I). Table 2 Hydrogen-bond geometry (Å , ) for (II). 
Database survey
A search of the Cambridge Crystallographic Database (CSD; Groom & Allen, 2014) returns only three crystal structures with the N-(tert-butyl)decahydroisoquinoline-3-carboxamide core. One of the structures is N-(tert-butyl)decahydroisoquinoline-3-carboxamide (CSD refcode COVYAO; Zhao et al., 2006) . The other two molecules are nelfinavir derivatives like (I) and (II), which were isolated during optimization of the synthesis. The difference between these two molecules comes via the substitution at the N-atom position of the decahydroisoquinoline group. One compound has a 3-amino-2-hydroxy-4-(phenylsulfanyl)butyl group in this position (CSD refcode QONJUY; Inaba et al., 2000) and the other has a 3-acetoxy-2-(3-acetoxy-2-methylbenzoylamino)-4-(phenylsulfanyl)butyl group at the Natom position (CSD refcode GONKOJ; Inaba et al., 1998) . Each of these molecules has intramolecular N-HÁ Á ÁO hydrogen bonding. In QONJUY it involves the two carboxyamide groups similar to the situation in compound (I). In GONKOJ it involves the N-tert-butyl carboxamide group and the 2-hydroxyl O atom similar to the situation in compound (II). The core structure of each of these previously reported materials is similar to (I) and (II) in that both six-membered rings of the decahydroisoquinoline groups adopt chair conformations. The dihedral angle between the best-fit planes of the cyclohexyl and piperidine moieties for the 3-amino-2-hydroxy-4-(phenylsulfanyl)butyl-substituted molecule is 117.1 (18) . Similarly, this angle for the 3-acetoxy-2-(3-acetoxy-2-methylbenzoylamino)-4-(phenylsulfanyl)butyl-substituted molecule is 116.8 (14) .
Synthesis and crystallization
Compound (I) was synthesized through the intermediate chloromethyl hydroxy 4 (Fig. 1 ). Chloromethyl ketone 3 (571 mg, 2.36 mmol) was dissolved in dichloromethane (7 ml) and methanol (4 ml) under nitrogen. The reaction was cooled to 273 K and sodium borohydride (63 mg, 1.65 mmol) was added in one portion. The reaction was stirred cold for 1h before being quenched by the slow addition of 2 M HCl (2 ml). A plot of the packing of (II) The solution was degassed for 30 min before being placed under 1 atm of hydrogen and stirred for 2 h at room temperature. The reaction was filtered through celite, dried to a solid, and taken up in tetrahydrofuran (5 ml). 2-Chloro-4-nitrobenzoic acid (52 mg, 0.256 mmol), 3-[3-(dimethylamino)propyl]-1-ethylcarbodiimide hydrochloride (49 mg, 0.256 mmol), and hydroxybenzotriazole hydrate (42 mg, 0.256 mmol) were added and the reaction was stirred at room temperature overnight. The reaction was taken up in ethyl acetate, washed once with sodium bicarbonate and once with brine, and dried over sodium sulfate. The product was purified by silica flash-column chromatography (gradient of 0-3% MeOH in DCM) to yield (I) as a yellow solid (yield 77 mg, 67%). Crystals suitable for X-ray diffraction were obtained from the vapor diffusion of pentane into a solution of compound (I) in ethyl acetate at room temperature.
1 H NMR (500 MHz, CDCl 3 ): 8.41 (q, J = 4 Hz, 1H), 8.24 (d, J = 2 Hz, 1H), 8.13 (dd, J1 = 2 Hz, J2 = 8.5 Hz, 1H), 7.76 (d, J = 8.5 Hz, 1H), 5.60 (s, 1H), 4.04 (m, 2H), 3.47 (dt, J1 = 4 Hz, J2 = 14 Hz, 1H), 3.35 (br, 1H), 2.71 (dd, J1 = 2 Hz, J2 = 11.5 Hz, 1H), 2.49 (dd, J1 = 3 Hz, J2 = 11.5 Hz, 1H), 2.36 (dd, J1 = 10 Hz, J2 = 12.5 Hz, 1H), 2.22 (dd, J1 = 5 Hz, J2 = 12.5 Hz, 1H), 2.18 (dd, J1 = 3 Hz, J2 = 11.5 Hz, 1H), 1.95 (q, J = 12 Hz, 1H), 1.80-1.08 (complex, 20H).
13 C NMR (500 MHz, CDCl 3 ): 174. 16, 167.06, 148.39, 142.00, 132.80, 130.18, 124.96, 121.56, 70.40, 68.29, 59.09, 57.54, 51.27, 43.27, 35.83, 33.55, 31.02, 30.86, 28.39, 26.19, 25.52, 20.18 (Fig. 2 ). Chloromethyl ketone 6 (860 mg, 3.05 mmol) was dissolved in dichloromethane (7 ml) and methanol (4 ml) under nitrogen. The reaction was cooled to 273 K and sodium borohydride (81 mg, 2.14 mmol) was added in one portion. The reaction was stirred cold for 1h before being quenched by the slow addition of 2 M HCl (2 ml). The reaction was dried and the solid was dissolved in ethyl acetate. The product was washed twice with water and once with brine, dried over sodium sulfate, and concentrated by rotary evaporation. Thin-layer chromatography (TLC) analysis showed two diastereomers with the higher R F compound being the (S,R) product. Both diastereomers were purified by silica flash-column chromatography (gradient of 0-10% EtOAc in DCM) to yield the (S,S)-isomer as a white solid (yield 279 mg, 32%) and (S,R)-isomer (7) as a white solid (yield 429 mg, 50%). Characterization of the (S,R)-isomer (7) (II), compound 8 (218 mg, 0.620 mmol) was dissolved in tetrahydrofuran (6 ml) with 2-chloro-4-nitrobenzoic acid (138 mg, 0.682 mmol), 3-[3-(dimethylamino)propyl]-1-ethylcarbodiimide hydrochloride (131 mg, 0.682 mmol), and hydroxybenzotriazole hydrate (111 mg, 0.682 mmol). The reaction was stirred at room temperature overnight. The reaction was taken up in ethyl acetate, washed once with sodium bicarbonate and once with brine, and dried over sodium sulfate. The product was purified by silica flash-column chromatography (gradient of 0-5% MeOH in DCM) to yield (II) as a yellow solid (yield 248 mg, 72%). Crystals suitable for X-ray diffraction were obtained by layering pentane over a solution of compound (II) in dichloromethane at room temperature. 
13
C NMR (500 MHz, CDCl 3 ): 173.83, 172.95, 148.31, 142.45, 128.53, 124.96, 122.35, 121.69, 69.81, 69.73, 60.88, 58.37, 57.98, 50.55, 50.51, 49.05, 35.84, 33.23, 31.07, 30.80, 28.56, 28.20, 26.20, 25.46, 24.53, 20.16 
Refinement
Crystal data, data collection and structure refinement details for (I) and (II) are summarized in Table 3 . Structural models consisting of the target molecules were developed for (I) and (II). Several disordered sites on each molecule were modeled with disorder. In each case, like distances were restrained to be similar. Since the major and minor components of each disordered site are in such close proximity to each other, the displacement parameters were constrained to be equal. Methyl H atom positions, R-CH 3 , were optimized by rotation about R-C bonds with idealized C-H, R-H and HÁ Á ÁH distances. All hydroxy and amine H atoms were located in a difference Fourier map in good hydrogen-bonding environments (Hamilton & Ibers, 1968) and their distances were allowed to refine. The O4-H4B distance in (II) was restrained to be 0.84 (2) Å . The remaining H atoms were included as riding idealized contributors. Methyl, hydroxy and amine H atomU values were assigned as 1.5 times U eq of the carrier atom; remaining H atom U values were assigned as 1.2 times the carrier atom U eq . On the basis of 2237 unmerged Friedel opposites, the fractional contribution of the inverted twin component was negligible (Flack, 1983; Flack & Bernardinelli, 2000) for (I). The absolute structure parameter y was calculated using PLATON (Spek, 2009). The resulting value was y = À0.010 (19), indicating that the absolute structure has been determined correctly (Hooft et al. 2008) . On the basis of 2720 unmerged Friedel opposites, the fractional contribution of the inverted twin component was negligible (Flack, 1983; Flack & Bernardinelli, 2000) for (II). The absolute structure parameter y was calculated using PLATON (Spek, 2009). The resulting value was y = 0.03 (2) indicating that the absolute structure has been determined correctly (Hooft et al. 2008 
Computing details
For both compounds, data collection: APEX2 (Bruker, 2014 ); cell refinement: SAINT (Bruker, 2014) ; data reduction:
SAINT (Bruker, 2014) , XPREP (Bruker, 2014) , and SADABS (Bruker, 2014 ). Program(s) used to solve structure: 
Special details
Experimental. One distinct cell was identified using APEX2 (Bruker, 2014) . Four frame series were integrated and filtered for statistical outliers using SAINT (Bruker, 2014) then corrected for absorption by integration using SHELXTL/XPREP V2005/2 (Bruker, 2014) before using SAINT/SADABS (Bruker, 2014) 
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